Cracking The Code: Understanding Analyst Reviews For Healthpeak Properties

Analysts' ratings for Healthpeak Properties (NYSE:DOC) over the last quarter vary from bullish to bearish, as provided by 7 analysts.The table below provides a snapshot of their recent ratings, showca

BenzingaMay 16 22:00

Scotiabank Maintains Sector Outperform on Healthpeak Properties, Raises Price Target to $23

Scotiabank analyst Nicholas Yulico maintains Healthpeak Properties with a Sector Outperform and raises the price target from $22 to $23.

Analyst UpgradesMay 16 21:25

Healthpeak Properties Is Maintained at Neutral by JP Morgan

Healthpeak Properties Is Maintained at Neutral by JP Morgan

Dow JonesMay 16 20:40

Komo: Maintaining the Healthpeak Properties (DOC.US) rating, adjusted from neutral to neutral, and adjusted the target price from $19.00 to $21.00.

Komo: Maintaining the Healthpeak Properties (DOC.US) rating, adjusted from neutral to neutral, and adjusted the target price from $19.00 to $21.00.

Zhitong FinanceMay 16 20:32

JPMorgan Adjusts Price Target on Healthpeak Properties to $21 From $19, Keeps Neutral Rating

Healthpeak Properties (DOC) has an average rating of outperform and price targets ranging from $18 to $30.50, according to analysts polled by Capital IQ. Price: 20.36, Change: +0.11, Percent Change: +

MT NewswiresMay 16 17:58

Real Estate Stocks Continue to Outperform Broader Markets With Increased Chances of Rate Cut

Seeking AlphaMay 12 00:00